(Q40582980)

21 September 2017

title

Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitors (English)

1 reference

21 September 2017

2

Marc E Lippman

1 reference

21 September 2017

1

James M Rae

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Breast Cancer Research and Treatment

21 September 2017

published in

1 reference

21 September 2017

volume

83

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

99-107

1 reference

https://scigraph.springernature.com/pub.10.1023/b:brea.0000010702.10130.29

21 September 2017

exact match

0 references

cites work

Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

EGF receptor in neoplasia and metastasis

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF.

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000010702.10130.29

7 January 2021

10.1023/B:BREA.0000010702.10130.29

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1032137777

0 references

1 reference